期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

子宫内膜癌患者保留卵巢功能的探讨 被引量：6

原文传递
导出
摘要 在欧美等发达国家,子宫内膜癌的发病率高居女性生殖道恶性肿瘤的首位。在我国北京、上海等经济发达城市及地区,由于人们生活方式的转变和宫颈癌筛查的普及,子宫内膜癌的发病率已于近年超过宫颈癌跃居成为女性生殖道恶性肿瘤的首位。从全球来看,2008年该病的发病例数约为287 100例,位居女性生殖道恶性肿瘤的第2位。
作者 郄明蓉 张竹
机构地区 四川大学华西第二医院妇产科
出处 《中华妇幼临床医学杂志（电子版）》 CAS 2014年第5期1-3,共3页 Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition)
基金 四川省科技支撑计划项目(2012SZ0021)
关键词 子宫内膜癌 保留卵巢功能 女性生殖道恶性肿瘤 癌患者 宫颈癌筛查 发达国家 生活方式 发病率
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献2

二级参考文献21

  • 1马瑛,彭芝兰,杨谨.子宫内膜癌卵巢转移危险因素及保留卵巢的可行性探讨[J].实用妇产科杂志,2005,21(12):741-744. 被引量：14
  • 2廖彩森 张绍基 杨学志.宫颈癌流行因素分析-306对配对调查.中华肿瘤杂志,1986,8(6):444-444.
  • 3Esteve J, Benhamou E, Raymond L. Statistical Methods in Cancer Research Volume IV, Descriptive Epidemiology [ M ].IARC Scientific Publications, No 128, Lyon, 1994.
  • 4Coleman MP, Esteve J, Damiecki P, et al. Trends in Cancer Incidence and Mortality [ M ]. IARC Scientific Publications,1993, 121.
  • 5Herrinton LJ, Stanford ]L, Schwartz SM, et al. Ovarian cancer incidence among Asian migrants to the United States and their descendents[J]. ] Nail Cancer Inst, 1994, 86(1):1336.
  • 6Titus-Ernstoff L, Perez K, Cramer DW, et al. Menstrual and reproductive factors in relation to ovarian cancer risk[J ]. Br J Cancer, 2001, 84(5): 714.
  • 7Zhang M, Yang ZY, Binns CW, et al. Diet and ovarian cancer risk: a ease-control study in China[J]. Br J Cancer, 2002, 86 (5) : 712.
  • 8Gao YT, Shu XO, Dai Q, et al. Association of menstrual and reproductive factors with breast cancer risk; results from the Shanghm breast cancer study[J]. Int J Cancer, 2000, 87:295.
  • 9Percy CL, Miller BA, Gloeelder Ries LA. EHeet of changes in cancer classification and the accuracy of cancer death certificates ontrends in cancer mortality[J]. Ann NY Acad Sci, 1990,609: 687.
  • 10Shu XO, Brinton LA, Zheng W, et al. Relation of obesity and body fat distribution to endometrial cancer in Shanghai, China [J]. Cancer Res,1992, 52:3865.

共引文献61

同被引文献56

  • 1王丽,张家文.子宫内膜癌保留卵巢功能的治疗对患者预后的影响[J].中国医药导报,2007,4(12Z):26-27. 被引量：6
  • 2Mantzos F, Vanakara P, Samara S,et al. Leptin receptor expression in neoplastic and normal ovarian and endometrial tissue[J]. Eur J Gynaecol Oncol, 2011,32(1):84-86.
  • 3Mihu D, Ciortea R, Mihu CM. Abdominal adiposity through adipocyte secretion products,a risk factor for endometrial cancer [J]. Gynecol Endocrinol, 2013,29(5) :448-451.
  • 4Ward KK, Mchale MT. Uterine corpus cancers// Eskander RN, Bristow RE. Gynecologic oncology [M]. New York Springer, 2015: 133-174.
  • 5Kim MK, Yoon BS, Park H, et al. Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women pilot study[J]. Int J Gynecol Cancer, 2011, 21 (4) : 673-677.
  • 6Vandenput I, Van Eygen K, Moerman P, et al. Ineffective attempt to preserve fertility with a levonorgestrel-releasing intrauterine device in a young woman with endometrioid endometrial carcinoma: a case report and review of the literature[J]. Eur J Gynaecol Oncoi, 2009, 30(3): 313-316.
  • 7Koh WJ, Greer BE, Abu-Rustum NR, et al. The NCCN endometrial neoplasm clinical practice guidelines in oncology (version 2. 2016)[EB/OL]. [2015-12-01]. http://nccn, org/ clinical trials/physician, html.
  • 8Carp HJA. Progestogens in obstetrics and gynecology[M]. Switzerland: Springer, 2015: 159.
  • 9Moe BT, Vereide AB, Orbo A, et al. Levonorgestrel, medroxyprogesterone and progesterone cause a concentration- dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy[J]. Anticancer Res, 2009, 29(4) 1047-1052.
  • 10Zhao X, Tang X, Ma T, et al. Levonorgestrel inhibits human endometrial cell proliferation through the upregulation of gap junctional intercellular communication via the nuclear translocation of Ser255 phosphorylated Cx43[J].Biomed Res Int, 2015: 758684.

引证文献6

二级引证文献10

中华妇幼临床医学杂志（电子版）
2014年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部